首站-论文投稿智能助手
典型文献
Glucose Metabolism and Human Immunodeficiency Virus Type 1 Infection
文献摘要:
Acquired immune deficiency syndrome is still one of the most severe global infectious diseases that pose a significant threat to human health. With the successful application of antiretroviral therapy, productive replication of human immunodeficiency virus type 1 (HIV-1) can be effectively blocked; however, antiretroviral therapy alone cannot cure the infection because of the presence of a stable and reactivatable viral latent reservoir. Thus, it is of great importance to have a better comprehension of the mechanisms driving HIV-1 pathogenesis and long-term persistence in infected individuals, based on which to further discover novel targets for therapeutic applications to treat or even cure the infection. Various studies have revealed that cellular metabolism is a critical factor impacting the fate and intracellular activities of immune cells. Emerging evidence implies that the alternations of cellular metabolism induced by HIV-1 infection play an important role in HIV-1 pathogenesis. Consequently, a promising approach of "metabolism as a therapeutic target" raised the possibility of using metabolic reprogramming as a treatment option for chronic HIV-1 infection. In this review, we summarize the latest studies about the interplay of the hosts' reprogramming of glucose metabolism and HIV-1 infection and introduce potential applications of searching for hallmarks and therapeutic targets of metabolic interventions for HIV-1 infection.
文献关键词:
HIV-1;Glucose metabolism;Metabolic reprogramming;Chronic inflammation
作者姓名:
Chen Zhonghe;Wang Tiantian;Deng Kai
作者机构:
Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China;Department of Immunology and Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China
引用格式:
[1]Chen Zhonghe;Wang Tiantian;Deng Kai-.Glucose Metabolism and Human Immunodeficiency Virus Type 1 Infection)[J].感染性疾病和免疫(英文),2022(04):242-247
A类:
reactivatable
B类:
Glucose,Metabolism,Human,Immunodeficiency,Virus,Type,Infection,Acquired,immune,syndrome,still,most,severe,global,infectious,diseases,that,pose,significant,threat,human,health,With,successful,antiretroviral,therapy,productive,replication,immunodeficiency,virus,type,HIV,effectively,blocked,however,alone,cannot,cure,infection,because,presence,stable,latent,reservoir,Thus,great,importance,have,better,comprehension,mechanisms,driving,pathogenesis,long,term,persistence,infected,individuals,which,further,discover,novel,targets,therapeutic,applications,even,Various,studies,revealed,metabolism,critical,impacting,fate,intracellular,activities,cells,Emerging,evidence,implies,alternations,induced,by,important,role,Consequently,promising,approach,raised,possibility,using,metabolic,reprogramming,treatment,option,chronic,this,review,summarize,latest,about,interplay,hosts,glucose,introduce,potential,searching,hallmarks,interventions,Metabolic,Chronic,inflammation
AB值:
0.612599
相似文献
Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners
Zhao Simin;Zheng Baisong;Wang Liuli;Cui Wenzhe;Jiang Chunlai;Li Zhuo;Gao Wenying;Zhang Wenyan-Center for Pathogen Biology and Infectious Diseases, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin 130021, China;College of Life Science of Jilin University, Changchun, Jilin 130012, China;Department of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130012, China;Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, Jilin 130041, China;Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, China
Low rate of pre-exposure prophylaxis and post-exposure prophylaxis uptake and high prevalence of transmitted drug resistance among newly diagnosed primary HIV infections in Shenzhen, China: a real-world retrospective study
Peng Qiaoli;Liu Xiaoning;Tang Xian;Zhang Qiuyue;Zhao Jin;Zheng Chenli;Zhao Fang;Zhou Yang;Zhang Lukun;Sun Liqin;Zhang Haitao;Jia Xinyun;Song Ying;Cao Tingzhi;Wang Siyuan;Rao Man;Chen Zhiwei;Wang Hui;He Yun-National Clinical Research Center for Infectious Diseases, HKU AIDS Institute Shenzhen Research Laboratory, The Third People’s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong 518112, China;National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom;Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong 518073, China;Department of Microbiology, AIDS Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 999077, China
HIV reservoir: antiviral immune responses and immune interventions for curing HIV infection
Li Shuang;Moog Christiane;Zhang Tong;Su Bin-Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;Laboratoire d' ImmunoRhumatologie Moléculaire, Institut national de la santé et de la recherche médicale (INSERM) UMR_S 1109, Institut thématique interdisciplinaire (ITI) de Médecine de Précision de Strasbourg, Transplantex NG, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg 67000, France
Biosafety assessment of delivery systems for clinical nucleic acid therapeutics
Li Zhimin;Zhang Li;Jiang Kai;Zhang Yijing;Liu Yonglin;Hu Guang;Song Jie-School of Molecular Medicine, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China;Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, The Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou 310022, China;School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China;Institute of Nano Biomedicine and Engineering, Department of Instrument Science and Engineering, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China;School of Life Sciences, Tianjin University, Tianjin 300350, China;School of Biomedical Sciences, Hunan University, Changsha 410082, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。